(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Tesis doctorales y Tesinas > Facultad de Medicina - Tesis Doctorales y Tesinas > Facultad de Medicina - Tesis Doctorales y Tesinas - 2010-2019 >

El papel de la FAK en la acantólisis del Pénfigo vulgar en un modelo murino
Autor(es) : Gil-Sanchez, M.P. (María Pilar)
Director(es) : Lopez-Zabalza, M.J. (María Jesús)
España, A. (Agustín)
Palabras clave : Materias Investigacion::Ciencias de la Salud::Dermatología
Modelo murino
Acantólisis
Pénfigo vulgar
Fecha incorporación: 2012
Fecha de la defensa: 20-abr-2012
Editorial : Servicio de Publicaciones de la Universidad de Navarra
ISBN: 978-84-8081-289-4
Cita: GIL SÁNCHEZ, María Pilar. “El papel de la FAK en la acantólisis del Pénfigo vulgar en un modelo murino”. España, Agustín y López-Zabalza, María Jesús. Tesis doctoral. Universidad de Navarra, 2012
Resumen
Pemphigus vulgaris (PV) is an autoimmune blistering skin disease characterized by suprabasal acantholysis, and autoantibodies against desmoglein 3 localized on desmosomes. In addition, caspases also seem to participate in this blistering disease. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase involved in cytoskeleton remodelling and formation and disassembly of cell adhesion structures. We have previously demonstrated that HER (human epidermal growth factor receptor related) isoforms, Src (Rous sarcoma) and mTOR (mammalian target of rapamycin), three molecules implicated in signalling processes, take part in suprabasal acantholysis and apoptosis induced by PV-IgG in a mouse model. Our aim was to investigate if upregulation of FAK is implicated in the development of PV lesions. Herein, using a mouse model, PV-IgG administration showed an increased level of FAK phosphorylated on 397 and 925 tyrosine residues in the basal layer of epidermis. When mice were pretreated with a FAK inhibitor the acantholysis of the basal layer of epidermis was absent. More interestingly, we observed that phosphorylated FAK (Y397/925) decreased when HER isoforms, Src, mTOR, and pan-caspases inhibitors were employed before PV-IgG administration. In addition, pretreatment with the FAK inhibitor before PV-IgG injection avoided the changes of both Bax and Bcl-2 expression and caspases-9 and –3 activities induced by PV-IgG. Finally, FAK inhibitor reduced expression of phosphorylated Src and mTOR in the basal cells of epidermis. In conclusion, our data reveal a novel biochemical mechanism for phosphorylated FAK (Y397/925) in PV development involving HER isoforms, Src and mTOR kinases.
Enlace permanente: http://hdl.handle.net/10171/22532
Aparece en las colecciones: DA - Medicina - Tesis doctorales
Facultad de Medicina - Tesis Doctorales y Tesinas - 2010-2019

Ficheros en este registro:
Fichero:  Tesis MPilar Gil Sánchez.pdf
Descripción: 
Tamaño:  3,62 MB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.